(MENAFN- Investor Brand Network) DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, is reporting on its fourth-quarter and full-year 2023 financial results; the company also releases a corporate and commercial update. Highlights of the report include $20.4 million full-year 2023 revenue, down from 2022 revenue of
$7.3
due to a managed
decrease in B2C and strategic milestone revenue as the core business-to-business-to-consumer (“B2B2C”) revenue increased; B2B2C, employers and health plans recurring revenues increased 39% year over year; commercial revenues brought in the majority of the revenue with B2B2C growing from 13% to 25% of total revenue from 2022 to 2023; GAAP operating expenses decreased by 11.2% sequentially from the third quarter of 2023 with Non-GAAP operating expenses down 9.4% sequentially from the third quarter; and total pro forma nonaudited revenues of approximately
$38 million
for the integrated entity in 2023. In addition, the report noted that Dario had signed multiple customers onto the Aetna platform, which launched in Q1 2024; the company also reported significant interest and multiple employer adoption of its GLP-1 Behavioral Change Program.“[Last year] was a very significant year for Dario,” said DarioHealth CEO Erez Raphael in the press release.“Our financial profile continued to improve as a result of our pivot to a business-to-business-to-consumer business model with growing B2B2C revenue and decreasing operating costs. . . . Last month we announced the transformational acquisition of Twill Inc., accompanied by a
$22.4 million
equity financing. We believe this acquisition propels Dario forward, creating immediate scale with three of the top eight national health plans, some of the largest technology companies and several major pharmaceutical companies as customers. Following the recent acquisition of Twill, we have commenced selling our new combined offerings and have begun the integration process and expect to report outcomes in the coming quarters. We believe that this acquisition completely transforms Dario and firmly establishes it as one of the leaders in the space, that understands how to leverage organic and inorganic growth to improve financial metrics and manage responsible growth. We ended the year with a strong cash position of
$37 million, not including the $22.4 million financing in the first quarter of 2024, which we believe puts us in a great position to execute our strategy.”
To view the full press release, visit
About DarioHealth Corp.
DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company's user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions glCFobally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers.
For more information about the company, please visit
.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company's newsroom at
About TinyGems
TinyGems
is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within
the
Dynamic Brand Portfolio
@
IBN
that delivers :
(1) access to a vast network of wire solutions via
InvestorWire
to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ;
(2) article and
editorial syndication to 5,000+ outlets ;
(3) enhanced
press release enhancement
to ensure maximum impact ;
(4)
social media distribution
via IBN to millions of social media followers ;
and (5) a full array of tailored
corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from TinyGems, text“Gems” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit
Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published:
/Disclaimer
TinyGems
Los Angeles, CA
310.299.1717 Office
...
TinyGems is powered by
IBN
MENAFN28032024000224011066ID1108035303
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.